Every tumor is different from patient to patient. This has led to the personalized treatment of cancer.
Tumors are complex mixtures of cells, and some cells will resist treatment. To improve treatment outcomes, new technology is needed to recover and test these variant cancer cell subpopulations.
We are developing new technology that provides the ability to rapidly recover live cancer cells from tumors, blood and related biological samples, in a sterile environment, for downstream testing. This will afford the opportunity to optimize treatment selections and improve patient care.
Please contact us with any questions at email@example.com.